Videos

Biomarkers for bladder cancer

The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

  • Webinar Prof. J.A Witjes (Urologist): Follow-up of NMIBC, Including the Place of Urinary MarkersProf. J.A Witjes (Urologist)

    Webinar Prof. J.A Witjes (Urologist): Follow-up of NMIBC, Including the Place of Urinary MarkersProf. J.A Witjes (Urologist) A webinar by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands and chaired by Dr. Dov Engelstein, Chairman of the Israel Association of Urology (IAU), and Dr. Ran Katz, Associate in the Israel Association of Urology (IAU).

    Play

    Webinar Prof. J.A Witjes (Urologist): Follow-up of NMIBC, Including the Place of Urinary MarkersProf. J.A Witjes (Urologist) A webinar by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands and chaired by Dr. Dov Engelstein, Chairman of the Israel Association of Urology (IAU), and Dr. Ran Katz, Associate in the Israel Association of Urology (IAU).

  • Prof. J.A Witjes (Urologist)

    Prof. J.A Witjes (Urologist) Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

    Play

    Prof. J.A Witjes (Urologist) Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

  • Gerard Lensvelt (Patient)

    Gerard Lensvelt (Patient) Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

    Play

    Gerard Lensvelt (Patient) Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

  • Rob De Vos (Patient)

    Rob De Vos (Patient) Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

    Play

    Rob De Vos (Patient) Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    The burden of non-muscle invasive bladder cancer (NMIBC) surveillance and the role of biomarkers

Bladder EpiCheck Symposium EAU19

Leading Change in NMIBC Monitoring-Insights from Successful Implementation of Bladder EpiCheck in Clinical Routine

  • Prof. J.A Witjes

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Introduction.

    Play

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Introduction.

  • Prof. J.A Witjes

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Bladder EpiCheck results - impact on my clinical practice.

    Play

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Bladder EpiCheck results - impact on my clinical practice.

  • Prof. S. Lerner

    Prof. S. Lerner Baylor College of Medicine Medical Center, USA

    Utilization of cystoscopy, cytology and Bladder EpiCheck – when best to use each one and why?

    Play

    Prof. S. Lerner Baylor College of Medicine Medical Center, USA

    Utilization of cystoscopy, cytology and Bladder EpiCheck – when best to use each one and why?

  • Prof. P. F. Bassi

    Prof. P. F. Bassi Università Cattolica del Sacro Cuore, Foundation "A. Gemelli" University Hospital, Largo Francesco Vito, Rome, Italy

    Utilization of Bladder EpiCheck in high-risk population – experience from a large referral center.

    Play

    Prof. P. F. Bassi Università Cattolica del Sacro Cuore, Foundation "A. Gemelli" University Hospital, Largo Francesco Vito, Rome, Italy

    Utilization of Bladder EpiCheck in high-risk population – experience from a large referral center.

  • Dr. C. D’Elia

    Dr. C. D’Elia Central Hospital of Bolzano, Bolzano, Italy

    Adding Bladder EpiCheck to cytology to improve NMIBC detection – experience from a regional public hospital.

    Play

    Dr. C. D’Elia Central Hospital of Bolzano, Bolzano, Italy

    Adding Bladder EpiCheck to cytology to improve NMIBC detection – experience from a regional public hospital.

  • Prof. R. Miano

    Prof. R. Miano Università di Roma Tor Vergata, Rome, Italy

    Bladder EpiCheck as a tool to reduce re-TURBT – Pilot study results.

    Play

    Prof. R. Miano Università di Roma Tor Vergata, Rome, Italy

    Bladder EpiCheck as a tool to reduce re-TURBT – Pilot study results.

  • Dr. A. Breda

    Dr. A. Breda Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain

    Bladder EpiCheck in upper tract tumors -feasibility study results.

    Play

    Dr. A. Breda Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain

    Bladder EpiCheck in upper tract tumors -feasibility study results.

  • Prof. J.A Witjes

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Summary.

    Play

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Summary.

BLADDER EPICHECK SYMPOSIUM, EAU18

Breaking the Glass Ceiling of Urine Markers in NMIBC Monitoring

  • Prof. J.A Witjes

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Introduction / European Multi-Center Study Results / Conclusions

    Play

    Prof. J.A Witjes Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

    Introduction / European Multi-Center Study Results / Conclusions

  • Prof. J.W.F Catto

    Prof. J.W.F Catto University of Sheffield, Sheffield, UK

    Clinical implementation of Bladder EpiCheck in NMIBC monitoring

    Play

    Prof. J.W.F Catto University of Sheffield, Sheffield, UK

    Clinical implementation of Bladder EpiCheck in NMIBC monitoring

  • Prof. S. Shariat

    Prof. S. Shariat Vienna General Hospital, Medical University of Vienna, Vienna, Austria

    How does Bladder EpiCheck change my decision making for patients with NMIBC.

    Play

    Prof. S. Shariat Vienna General Hospital, Medical University of Vienna, Vienna, Austria

    How does Bladder EpiCheck change my decision making for patients with NMIBC.

  • Prof. R. Miano

    Prof. R. Miano Università di Roma Tor Vergata, Rome, Italy

    Bladder EpiCheck research beyond NMIBC monitoring

    Play

    Prof. R. Miano Università di Roma Tor Vergata, Rome, Italy

    Bladder EpiCheck research beyond NMIBC monitoring

STAY UPDATED ON THE LATEST NEWS FROM NUCLEIX!

SOCIAL MEDIA

Subscribe to one of our social media channels

close

Subscription Confirmation Required

Go to your email inbox

Go to your email inbox

Go to the inbox of the email
address you just used to sign up.

Open the confirmation email

Open the confirmation email

Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.

Click the confirmation link

Click the confirmation link

Click on the link inside the
email and you’re good to go.

GOT IT !